-- Magna Terra Minerals（MTT.V）週四宣布收購位於紐芬蘭西部的Shellbird金礦計畫。 該計畫沿著區域性杜瑟谷斷層帶（DVFZ）延伸，由五個礦權區組成，總面積達30,650公頃。 該計畫涵蓋了長達35公里的區域性杜瑟谷斷層帶及其相關分支斷層。 「此前，礦區曾進行過早期貴金屬勘探，並取得了一些令人鼓舞的抓取樣品結果，最高品位達2.33克/噸，但這些結果並未得到後續跟進。我們的團隊很高興能在今年春天完成這項至關重要的勘探工作。」執行長Lew Lawrick表示。 該公司股票在多倫多證券交易所創業板（TSX Venture Exchange）的最新交易價格上漲0.005加元，至0.165加元。
Price: $0.17, Change: $+0.01, Percent Change: +3.13%
Galloper Gold (BOOM.CN) on Thursday said it plans to begin a 2026 drilling program at Glover Island targeting new high-grade gold targets in the Lunch Pond South Extension (LPSE) gold deposit.The company also plans regional exploration drilling, particularly at Lucky Smoke.An updated geological modelling and engineering exercise resulted in the recently released and increased LPSE Mineral Resource Estimate (MRE), said the company and added that the 2026 drilling program will follow-up and build on this "momentum."The 2026 drilling program is expected to include up to 7,000 meters of diamond drilling in over 25 boreholes. Drilling will target along-strike and down-dip continuity of the LPSE and Lucky Smoke gold deposits within the Kettle Pond formation, the company added."Galloper Gold Corp. has been comprehensively evaluating the Kettle Pond Formation gold mineralized trend with historical data, and, as a result of this, we have recently released an updated MRE for the LPSE deposit," said chief executive Hratch Jabrayan. "This effort has resulted in a new understanding of the geological architecture of the property and has built targeting for additional gold mineralization intercepts."Shares of the company were last seen unchanged at $0.10 on the Canadian Securities Exchange.
United Therapeutics (UTHR) still has a stronger long-term growth path despite a soft Q1, helped by Tyvaso durability, possible idiopathic pulmonary fibrosis expansion, TreSMI filing plans, and future upside from ralinepag, RBC Capital Markets said in a note emailed Thursday.The investment firm said Tyvaso revenue missed estimates in Q1, but the firm expects the franchise to return to growth after weather issues and specialty pharmacy delays subside.IPF could become the company's next major growth driver, with a supplemental application still planned for this summer and other faster approval paths under review, RBC said.TreSMI remains on track for a US Food and Drug Administration filing in pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease by year's end, which could help United Therapeutics defend its position in inhaled treprostinil, according to the note.Ralinepag Dry Powder Inhalation could add longer-term upside because once daily dosing may help the company compete better in pulmonary hypertension and related lung disease markets, RBC added.RBC lowered its price target for United Therapeutics to $701 from $707 while keeping its outperform rating.Price: $576.22, Change: $-20.55, Percent Change: -3.44%
Klaviyo (KVYO) said Thursday it has expanded its integration with Anthropic to provide new agentic marketing workflows to the Claude AI model.Customers will be able to securely access and generate outputs from their customer and performance data through the connection of Klaviyo's Model Context Protocol server across Claude's products, according to a statement.Price: $15.84, Change: $+0.03, Percent Change: +0.18%